Recent Material Events - Valera Pharmaceutical (VLRX)

Filing Date	Description
2007-03-14	Stockholders of record as of March 12, 2007 will be mailed the joint proxy statement/prospectus in connection with the proposed merger and will be entitled to vote at the respective company’s special stockholder meeting. The joint proxy statemen... ...
2007-02-22	A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.... ...
2007-02-06	A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.... ...
2006-12-27	On December 21, 2006, Valera Pharmaceuticals, Inc. (the “ Company ”) entered into a Letter Agreement (collectively, the “ 409A Letter Agreements ”) with each of Andrew T. Drechsler, Jerry Middleton and Matthew Rue to amend the cha... ...
2006-12-15	The Co-Promotion Agreement will be filed as an exhibit at a subsequent date, with portions omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment. The foregoing description of the Co-... ...